For research use only. We do not sell to patients.
Patisiran sodium
CAS No. : 1386913-72-9
Biological Activity：Patisiran sodium is a double-stranded small interfering RNA that targets a sequence within the transthyretin (TTR) messenger RNA. Patisiran sodium specifically inhibits hepatic synthesis of mutant and wild-type TTR. Patisiran sodium can be used for the research of hereditary TTR amyloidosis[2][3].
Research Area：Neurological Disease
Targets：Transthyretin (TTR)|Small Interfering RNA (siRNA)
Related Screening Libraries:Drug Repurposing Compound Library Plus;FDA-Approved Drug Library Plus;Bioactive Compound Library Plus;
Related Small Molecules:SLN124;Cemdisiran;Givosiran;Manusiran;Revusiran;AB-729;Teprasiran;Fazirsiran;Fitusiran;Inclisiran;Eplontersen;Acoramidis;Tivanisiran;Dichlorophenyl-ABA;Inotersen sodium;Lumasiran;Elebsiran;Lumasiran sodium;Zerlasiran;Vutrisiran
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
